BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31686588)

  • 21. Identification of a single-nucleotide polymorphism within
    Aaron M; Nadeau G; Ouimet-Grennan E; Drouin S; Bertout L; Beaulieu P; St-Onge P; Shalmiev A; Veilleux LN; Rauch F; Petrykey K; Laverdière C; Sinnett D; Alos N; Krajinovic M
    Pharmacogenomics; 2019 Apr; 20(6):409-420. PubMed ID: 30983502
    [No Abstract]   [Full Text] [Related]  

  • 22. Genetic risk factors for VIPN in childhood acute lymphoblastic leukemia patients identified using whole-exome sequencing.
    Abaji R; Ceppi F; Patel S; Gagné V; Xu CJ; Spinella JF; Colombini A; Parasole R; Buldini B; Basso G; Conter V; Cazzaniga G; Leclerc JM; Laverdière C; Sinnett D; Krajinovic M
    Pharmacogenomics; 2018 Oct; 19(15):1181-1193. PubMed ID: 30191766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Toft N; Birgens H; Abrahamsson J; Griškevičius L; Hallböök H; Heyman M; Klausen TW; Jónsson ÓG; Palk K; Pruunsild K; Quist-Paulsen P; Vaitkeviciene G; Vettenranta K; Asberg A; Helt LR; Frandsen T; Schmiegelow K
    Eur J Haematol; 2016 Feb; 96(2):160-9. PubMed ID: 25867866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early presentation of osteonecrosis in acute lymphoblastic leukemia: Two children from the Nordic and Baltic cohort.
    Mogensen SS; Harila-Saari A; Frandsen TL; Lähteenmäki P; Castor A; Kohonen I; Schmiegelow K; Mäkitie O
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28521072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteonecrosis in children with acute lymphoblastic leukemia.
    Kunstreich M; Kummer S; Laws HJ; Borkhardt A; Kuhlen M
    Haematologica; 2016 Nov; 101(11):1295-1305. PubMed ID: 27742768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
    Mattano LA; Sather HN; Trigg ME; Nachman JB
    J Clin Oncol; 2000 Sep; 18(18):3262-72. PubMed ID: 10986059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Replication analysis confirms the association of ARID5B with childhood B-cell acute lymphoblastic leukemia.
    Healy J; Richer C; Bourgey M; Kritikou EA; Sinnett D
    Haematologica; 2010 Sep; 95(9):1608-11. PubMed ID: 20460642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bim polymorphisms: influence on function and response to treatment in children with acute lymphoblastic leukemia.
    Gagné V; Rousseau J; Labuda M; Sharif-Askari B; Brukner I; Laverdière C; Ceppi F; Sallan SE; Silverman LB; Neuberg D; Kutok JL; Sinnett D; Krajinovic M
    Clin Cancer Res; 2013 Sep; 19(18):5240-9. PubMed ID: 23908358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteonecrosis in children with acute lymphoblastic leukemia: A report from Children's Cancer Hospital Egypt (CCHE).
    Ali N; Gohar S; Zaky I; Elghoneimy A; Youssef S; Sameer G; Yassin D; Salem S; Magdi H; Sidhom I
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27440. PubMed ID: 30183135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Family-based exome-wide association study of childhood acute lymphoblastic leukemia among Hispanics confirms role of ARID5B in susceptibility.
    Archer NP; Perez-Andreu V; Stoltze U; Scheurer ME; Wilkinson AV; Lin TN; Qian M; Goodings C; Swartz MD; Ranjit N; Rabin KR; Peckham-Gregory EC; Plon SE; de Alarcon PA; Zabriskie RC; Antillon-Klussmann F; Najera CR; Yang JJ; Lupo PJ
    PLoS One; 2017; 12(8):e0180488. PubMed ID: 28817678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
    Levien MG
    Clin Pediatr (Phila); 2002; 41(1):63-4. PubMed ID: 11866371
    [No Abstract]   [Full Text] [Related]  

  • 32. Genetic polymorphism of vitamin D receptors and plasminogen activator inhibitor-1 and osteonecrosis risk in childhood acute lymphoblastic leukemia.
    Sherief LM; Beshir M; Raafat N; Abdelkhalek ER; Mokhtar WA; Elgerby KM; Soliman BK; Salah HE; Mokhtar GA; Kamal NM; ELsayed H; Zakaria M
    Mol Genet Genomic Med; 2021 Jul; 9(7):e1700. PubMed ID: 34042331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On a case of multifocal osteonecrosis in a patient suffering from acute lymphoblastic leukemia.
    Solarino G; Scialpi L; Bruno M; De Cillis B
    Chir Organi Mov; 2008 Sep; 92(2):119-22. PubMed ID: 18473129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of aseptic osteonecrosis following the therapy of childhood leukemia.
    Bömelburg T; von Lengerke HJ; Ritter J
    Haematol Blood Transfus; 1990; 33():577-9. PubMed ID: 2323658
    [No Abstract]   [Full Text] [Related]  

  • 35. Whole-exome sequencing of a rare case of familial childhood acute lymphoblastic leukemia reveals putative predisposing mutations in Fanconi anemia genes.
    Spinella JF; Healy J; Saillour V; Richer C; Cassart P; Ouimet M; Sinnett D
    BMC Cancer; 2015 Jul; 15():539. PubMed ID: 26201965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management and treatment of osteonecrosis in children and adolescents with acute lymphoblastic leukemia.
    Te Winkel ML; Pieters R; Wind EJ; Bessems JH; van den Heuvel-Eibrink MM
    Haematologica; 2014 Mar; 99(3):430-6. PubMed ID: 24598854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A childhood acute lymphoblastic leukemia genome-wide association study identifies novel sex-specific risk variants.
    Singh SK; Lupo PJ; Scheurer ME; Saxena A; Kennedy AE; Ibrahimou B; Barbieri MA; Mills KI; McCauley JL; Okcu MF; Dorak MT
    Medicine (Baltimore); 2016 Nov; 95(46):e5300. PubMed ID: 27861356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired dexamethasone-related increase of anticoagulants is associated with the development of osteonecrosis in childhood acute lymphoblastic leukemia.
    te Winkel ML; Appel IM; Pieters R; van den Heuvel-Eibrink MM
    Haematologica; 2008 Oct; 93(10):1570-4. PubMed ID: 18698082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial.
    Mattano LA; Devidas M; Nachman JB; Sather HN; Hunger SP; Steinherz PG; Gaynon PS; Seibel NL;
    Lancet Oncol; 2012 Sep; 13(9):906-15. PubMed ID: 22901620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurobehavioral side effects of corticosteroids during active treatment for acute lymphoblastic leukemia in children are age-dependent: report from Dana-Farber Cancer Institute ALL Consortium Protocol 00-01.
    Mrakotsky CM; Silverman LB; Dahlberg SE; Alyman MC; Sands SA; Queally JT; Miller TP; Cranston A; Neuberg DS; Sallan SE; Waber DP
    Pediatr Blood Cancer; 2011 Sep; 57(3):492-8. PubMed ID: 21560226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.